---
title: "Torrent Pharmaceuticals Ltd (TORNTPHARM) — Share Price, Financials & Analysis"
symbol: "TORNTPHARM"
company: "Torrent Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/TORNTPHARM"
isin: "INE685A01028"
nse_symbol: "TORNTPHARM"
bse_code: "500420"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 186855.71
generated_at: "2026-09-13T19:26:07.577Z"
---

# Torrent Pharmaceuticals Ltd (TORNTPHARM)

Canonical page: https://tapetide.com/stocks/TORNTPHARM

## Company

- **NSE Symbol:** TORNTPHARM
- **BSE Code:** 500420
- **ISIN:** INE685A01028
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2002-11-25
- **CEO:** Mr. Aman Mehta
- **Employees:** 17059
- **Face Value:** ₹5
- **F&O Eligible:** Yes
- **Website:** torrentpharma.com

## About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]
It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

## Latest Price

- **Price:** ₹4965.5
- **Change:** +35.5 (+0.72%)
- **Open:** ₹4929
- **Day High:** ₹4988
- **Day Low:** ₹4894
- **Previous Close:** ₹4930
- **Volume:** 263114
- **As Of:** 2026-09-11T10:25:06+00:00

## Key Fundamentals

Observed at 2026-09-11T04:33:44.632761Z.

- **Market Cap:** ₹186855.71 Cr
- **Classification:** Largecap
- **P/E (reported):** 86.9
- **P/E (TTM):** 77.95
- **EPS (TTM):** ₹63.7
- **EPS (reported):** ₹49.44
- **Book Value:** ₹221.09
- **Price to Book:** 22.29
- **Dividend Yield:** 0.77%
- **ROE:** 12.16%
- **ROCE:** 9.06%
- **Debt to Equity:** 1.79
- **Revenue (yearly):** ₹13886.2 Cr
- **Net Income:** ₹2138.2 Cr
- **EBITDA:** ₹4464.9 Cr
- **52-Week High:** ₹5250
- **52-Week Low:** ₹3480.6
- **RSI (14):** 49.59

## Tapetide Score

- **Score:** 54 / 100
- **Score date:** 2026-09-04
- **Archetype:** Losing Momentum
- **What it means:** A capable business whose price trend has turned while the multiple is still demanding. Often a re-rating in progress rather than a broken company — watch whether earnings stay resilient.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Falling
- **Percentile:** 65.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 16.3 | 9% |
| growth | 91.78 | 9% |
| momentum | 34.79 | 12% |
| ownership | 64.2 | 24% |
| quality | 69.87 | 22% |
| valuation | 38 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%
- Company has been maintaining a healthy dividend payout of 57.8%

### Weaknesses

- Stock is trading at 20.0 times its book value
- Promoter holding has decreased over last quarter: -7.53%
- The company has delivered a poor sales growth of 11.8% over past five years.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 16.93% | -7.45% | 67.65% |
| ebitda margin growth | 28.32% | -0.92% | 1.23% | 6.49% |
| net income growth | 55.49% | 11.87% | 22% | 12% |
| revenue growth | 17.32% | 20.34% | 13% | 12% |
| roce | 35.69% | -68.19% | -67.74% | 21.09% |
| roe | 55.49% | -51.71% | 20.5% | -6.89% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2660 | 2732 | 2745 | 2859 | 2889 | 2809 | 2959 | 3178 | 3302 | 3303 | 4197 | 4921 |
| Expenses | 1835 | 1863 | 1862 | 1955 | 1950 | 1895 | 1995 | 2146 | 2219 | 2215 | 2841 | 3257 |
| Operating Profit | 825 | 869 | 883 | 904 | 939 | 914 | 964 | 1032 | 1083 | 1088 | 1356 | 1664 |
| OPM % | 31 | 32 | 32 | 32 | 32 | 33 | 33 | 32 | 33 | 33 | 32 | 34 |
| Other Income | 26 | 55 | 31 | 24 | -16 | 33 | -42 | -37 | -40 | -23 | -83 | -33 |
| Interest | 91 | 80 | 80 | 75 | 64 | 57 | 56 | 56 | 48 | 45 | 236 | 305 |
| Depreciation | 201 | 213 | 203 | 197 | 198 | 199 | 201 | 201 | 204 | 206 | 508 | 593 |
| Profit before tax | 559 | 631 | 631 | 656 | 661 | 691 | 665 | 738 | 791 | 814 | 529 | 733 |
| Tax % | 31 | 30 | 29 | 30 | 31 | 27 | 25 | 26 | 25 | 22 | 31 | 23 |
| Net Profit | 386 | 443 | 449 | 457 | 453 | 503 | 498 | 548 | 591 | 635 | 364 | 566 |
| EPS in Rs | 11.41 | 13.09 | 13.27 | 13.5 | 13.38 | 14.86 | 14.71 | 16.19 | 17.46 | 18.76 | 10.76 | 16.72 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 5950 | 7673 | 7939 | 8005 | 8508 | 9620 | 10728 | 11516 | 13980 | 15723 |
| Expenses | 4601 | 5690 | 5769 | 5524 | 6077 | 6778 | 7360 | 7795 | 9421 | 10532 |
| Operating Profit | 1349 | 1983 | 2170 | 2480 | 2431 | 2842 | 3368 | 3721 | 4558 | 5191 |
| OPM % | 23 | 26 | 27 | 31 | 29 | 30 | 31 | 32 | 33 | 33 |
| Other Income | 299 | -300 | 121 | 57 | -288 | 45 | 146 | -1 | -182 | -179 |
| Interest | 308 | 504 | 451 | 353 | 255 | 333 | 354 | 252 | 385 | 634 |
| Depreciation | 409 | 618 | 654 | 658 | 662 | 707 | 808 | 795 | 1119 | 1511 |
| Profit before tax | 931 | 562 | 1187 | 1526 | 1226 | 1847 | 2352 | 2673 | 2872 | 2867 |
| Tax % | 27 | 22 | 14 | 18 | 37 | 33 | 30 | 28 | 26 | — |
| Net Profit | 678 | 436 | 1025 | 1252 | 777 | 1245 | 1656 | 1911 | 2138 | 2156 |
| EPS in Rs | 20.04 | 12.89 | 30.28 | 36.99 | 22.97 | 36.79 | 48.94 | 56.47 | 63.92 | 63.7 |
| Dividend Payout % | 35 | 66 | 53 | 47 | 105 | 60 | 57 | 57 | 59 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 85 | 85 | 85 | 85 | 85 | 85 | 169 | 169 | 169 | 169 |
| Reserves | 4266 | 4538 | 4640 | 4739 | 5753 | 5868 | 6029 | 6687 | 7421 | 8219 |
| Borrowings | 2510 | 6462 | 6038 | 5784 | 4874 | 4070 | 5369 | 4022 | 3202 | 15026 |
| Other Liabilities | 2740 | 3159 | 3351 | 3402 | 3363 | 2884 | 3043 | 3627 | 3603 | 20200 |
| Total Liabilities | 9601 | 14243 | 14113 | 14010 | 14075 | 12906 | 14610 | 14505 | 14396 | 43614 |
| Fixed Assets | 3688 | 7855 | 7748 | 7533 | 7065 | 6423 | 8121 | 8138 | 7947 | 33191 |
| CWIP | 519 | 647 | 617 | 712 | 889 | 630 | 765 | 361 | 478 | 641 |
| Investments | 804 | 492 | 353 | 2 | 181 | 226 | 199 | 173 | 156 | 948 |
| Other Assets | 4589 | 5249 | 5395 | 5763 | 5940 | 5628 | 5524 | 5834 | 5815 | 8833 |
| Total Assets | 9601 | 14243 | 14113 | 14010 | 14075 | 12906 | 14610 | 14505 | 14396 | 43614 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1009 | 894 | 1798 | 1393 | 2005 | 1803 | 2368 | 3266 | 2585 | 3023 |
| Cash from Investing Activity | -798 | -4677 | -246 | 229 | -444 | -196 | -2335 | -160 | -549 | -12630 |
| Cash from Financing Activity | -193 | 3417 | -1314 | -1549 | -1651 | -1781 | 77 | -2780 | -2298 | 10151 |
| Net Cash Flow | 18 | -366 | 238 | 73 | -89 | -174 | 110 | 327 | -262 | 544 |
| Free Cash Flow | 523 | 105 | 1138 | 990 | 1671 | 1607 | 1953 | 2967 | 1991 | 2386 |
| CFO/OP | 101 | 87 | 105 | 77 | 88 | 91 | 97 | 112 | 86 | 84 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 60 | 77 | 68 | 76 | 69 | 70 | 74 | 63 | 59 | 79 |
| Inventory Days | 318 | 429 | 318 | 362 | 456 | 368 | 298 | 310 | 334 | 338 |
| Days Payable | 356 | 447 | 345 | 345 | 351 | 250 | 224 | 284 | 239 | 254 |
| Cash Conversion Cycle | 21 | 59 | 42 | 93 | 174 | 188 | 147 | 89 | 154 | 163 |
| Working Capital Days | 28 | -80 | -62 | -52 | -5 | 7 | -33 | -27 | 7 | -26 |
| ROCE % | 19 | 13 | 13 | 15 | 17 | 19 | 20 | 23 | 27 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 71.25% | 71.25% | 71.25% | 71.25% | 71.25% | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% | 68.31% |
| FIIs | 0% | 14.08% | 14.14% | 14.22% | 14.46% | 16.17% | 16.31% | 16.09% | 15.92% | 16.13% | 16.18% | 15.44% |
| DIIs | 7.16% | 6.44% | 7.16% | 7.17% | 6.98% | 8.25% | 8.25% | 8.55% | 9.18% | 9.04% | 9.06% | 9.73% |
| Government | 0% | 0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0% | 0.1% |
| Public | 4.25% | 4.15% | 4.09% | 3.98% | 4.34% | 4.61% | 4.51% | 4.44% | 4.08% | 4.03% | 4.12% | 5.04% |
| Others | 17.34% | 4.08% | 3.27% | 3.28% | 2.87% | 2.56% | 2.52% | 2.5% | 2.41% | 2.38% | 2.33% | 1.38% |
| No. of Shareholders | 69612 | 69117 | 71154 | 74765 | 79848 | 85035 | 86005 | 81856 | 78226 | 76214 | 83811 | 85776 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 7 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 4950.55 | Buy |
| EMA (10) | 4944.76 | Buy |
| SMA (20) | 4952.43 | Buy |
| EMA (20) | 4944.67 | Buy |
| SMA (50) | 4947.9 | Buy |
| EMA (50) | 4879.85 | Buy |
| SMA (100) | 4683.25 | Buy |
| EMA (100) | 4711.59 | Buy |
| SMA (200) | 4362.42 | Buy |
| EMA (200) | 4414 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 52.16 | Neutral |
| MACD (12,26,9) | 6.49 | Sell |
| Stochastic (14,3,3) | 48.9 | Neutral |
| ADX (14) | 12.56 | Neutral |
| Williams %R (14) | -41.36 | Neutral |
| ATR (14) | 104.87 | Neutral |
| ROC (12) | 1.54 | Buy |
| Stoch RSI (14) | 50.13 | Neutral |
| UO (7,14,28) | 51.23 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 21 | 70% |
| Hold | 7 | 23.33% |
| Sell | 2 | 6.67% |

Based on 30 analyst ratings, observed at 2026-09-11T04:33:44.666323+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e17b028f-5647-458d-b140-16524eee955a.pdf) |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f16c293e-ef2a-4fe5-b990-b2aff1c413e8.pdf) |
| 2026-09-07 | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c60e315e-eb28-49e1-8648-67658e79b13d.pdf) |
| 2026-09-07 | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=372afc69-d469-4a5c-80b0-0644c852bf00.pdf) |
| 2026-08-11 | [Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fd8de91-b111-442a-9578-6cd7bb39ed20.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22244d03-074b-42bf-b88f-f287e50cf75f.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=032e0e4a-fec9-4821-ae1e-06d237255ecc.pdf) |
| 2026-08-05 | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=072c419d-4e78-496d-876f-86dac1df9eb4.pdf) |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=675e9770-7b12-4c67-bbdd-29ddb3303c7f.pdf) |
| 2026-08-01 | [Announcement under Regulation 30 (LODR)-Cessation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22284040-adbd-4deb-a7bf-13814e0fecad.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-30 | [Results For Quarter Ended 30-Jun-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db7e5e01-7e8b-4e02-99b5-76d6a2b8ec1e.pdf) |
| 2026-05-22 | [Results For Quarter And Year Ended 31-Mar-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0ae2872-2a30-44b7-8da2-1de1201fc96b.pdf) |
| 2026-02-13 | [Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ba88868-aea6-47c8-a579-284db0de7e1d.pdf) |
| 2025-11-07 | [Results For Quarter And Half Year Ended 30-Sep-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=259a8ec4-5486-4fff-b996-c50cbb37b964.pdf) |
| 2025-07-28 | [Results For Quarter Ended 30-Jun-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3499cf77-9c07-48a2-90f7-79c0f6a48c47.pdf) |
| 2025-05-20 | [Results Q4 And Year Ended 31-03-2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fee6381-8bc2-4f61-a825-ebdef58b7439.pdf) |
| 2025-05-20 | [Results Q4 And Year Ended 31-03-2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bd444ce-1a01-4b87-bc05-ba0818d8ba67.pdf) |
| 2025-01-24 | [Results Q3 FY 2024-25.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a199b25-0d02-4052-962c-07d2b7253658.pdf) |
| 2024-10-25 | [Results Q2 FY 2024-25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=670cce05-2558-40a7-8be0-98247cddf8b4.pdf) |
| 2024-07-23 | [Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f88c25d5-ebec-45d3-b778-c4be3d9b4ab4.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dee30566-673a-4d11-b4ec-c550be8ba1ba.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-05-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bbdf051-9a1e-44db-b14a-29bcaca463e2.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a21a5dda-e42b-4ebc-8af0-7be4a351e6bf.pdf) |
| 2025-11-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebdc13cb-482b-4c38-83de-1b7f1e166d6a.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c68ae7d-da12-4018-b0d7-901d89a709ad.pdf) |
| 2025-05-23 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb1d6559-1989-41bc-94c7-564eddae7ee8.pdf) |
| 2025-01-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcab31f7-0c14-4010-87d9-26f9c7e6497d.pdf) |
| 2024-10-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361f13b1-b2a6-421c-a368-19b26e108150.pdf) |
| 2024-07-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=222507ea-9b52-4e0d-80a7-83707abd39d9.pdf) |
| 2024-05-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e64c694c-2f62-47e1-8af0-9e16ffe40f50.pdf) |
| 2024-02-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7762fe1b-da9d-435a-8b80-f6286b6c31a9.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cff3798-967d-44b8-a6d1-8a17e7795c07.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22107ea0-c2a1-413e-b410-8421cc8389c0.pdf) |
| 2025-11-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e94e952-be35-4092-b775-7b3ece9ecce0.pdf) |
| 2025-07-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40893d7-5b78-43c0-b37c-50d1a127a763.pdf) |
| 2025-06-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6314da61-f7f2-42a3-a461-607c3a8f44ad.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09f70655-a2f4-4b63-8191-9e0d2855cbce.pdf) |
| 2025-01-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645825e0-582d-4814-9a5a-801fc99b4425.pdf) |
| 2024-10-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f39a280c-aac0-4ed9-bb13-d91f8fe6c9df.pdf) |
| 2024-07-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa02d9f7-5285-4cc8-83e4-d7e079c4d054.pdf) |
| 2024-05-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a717b30c-f348-44c7-9f3a-cad05e04b26a.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=251f905f-f731-4415-a46b-58521947b787.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f5eb2dc-03eb-4491-a721-94f41b46c08c.pdf) |
| 2025-11-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2874803-e241-4563-a280-50b13858696c.pdf) |
| 2025-07-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce2a2380-22dc-4cfd-a707-f7eec3b15cfd.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e31fd468-d11f-4370-835d-1a6eaea5755d.pdf) |
| 2024-10-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1405eb60-bba8-46f9-9018-8b33b6ff6021.pdf) |
| 2024-07-23 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ba1732-b394-4b51-85b5-676dffcb5ef2.pdf) |
| 2024-05-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9dece7aa-80ad-4bb4-a212-ce50e19c54b0.pdf) |
| 2024-02-02 | [Audio Recording Of Con-Call With Analyst / Investor On Financial Result For Quarter And Nine Months Ended 31.12.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ebffe4-7736-4517-8758-ab139c75c1fb.pdf) |
| 2023-08-07 | [Audio Recording Of Conference Call With Analysts / Investors On Financial Results For The Quarter Ended 30Th June, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf516e89-0edc-48e7-88a8-f3e191b8fb62.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8h - NCLT Ahmedabad uploaded order on 23-Mar-2026 for amalgamation of J.B. Chemicals into Torrent Pharma. | [Announcement Under Regulation 30 Of SEBI LODR - NCLT Order 8h - NCLT Ahmedabad uploaded order on 23-Mar-2026 for amalgamation of J.B. Chemicals into Torrent Pharma.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ad5eed0d-208e-4bb4-8e58-cbd385623eb1.pdf) |
| 7h - NCLT issued corrigendum (24 Mar 2026) to order approving J.B. Chemicals' amalgamation into Torrent Pharmaceuticals. | [Announcement Under Regulation 30 Of SEBI (LODR) - Corrigendum 7h - NCLT issued corrigendum (24 Mar 2026) to order approving J.B. Chemicals' amalgamation into Torrent Pharmaceuticals.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dd0aab7c-d0dc-4f62-a949-4198e6a8a6e6.pdf) |
| 6h - Newspaper cuttings of advertisement published - Notice of Hearing of Petition | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6h - Newspaper cuttings of advertisement published - Notice of Hearing of Petition](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ae735e43-8630-4fb7-aa7a-1009dadc4c1d.pdf) |
| 30 Mar - Sold 50,000 UNM Foundation shares for ₹5,00,000 to Torrent Investments on March 30, 2026. | [Sale Of Equity Shares Of UNM Foundation (Section 8 Company), Associate Company 30 Mar - Sold 50,000 UNM Foundation shares for ₹5,00,000 to Torrent Investments on March 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a847af7c-58e1-419a-a7f3-95dc81de6a80.pdf) |
| 2d - Newspaper Advertisement in respect of special window for transfer and dematerialization requests of physical shares | [Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - Newspaper Advertisement in respect of special window for transfer and dematerialization requests of physical shares](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ba5942ac-eac4-4c17-8d09-fbc7bdac45ef.pdf) |
| 2d - Board meeting on 22-May-26 to approve FY26 audited results, consider final dividend, and possible QIP/DR issue. | [Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (LODR) Regulations, 2015 2d - Board meeting on 22-May-26 to approve FY26 audited results, consider final dividend, and possible QIP/DR issue.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/aece72cc-8c8e-4954-b37a-3c162a728541.pdf) |
| 28 Mar - Newspaper Publication - Details of NCLT Convened Meeting of Equity Shareholders | [Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Mar - Newspaper Publication - Details of NCLT Convened Meeting of Equity Shareholders](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1056c516-41fb-4b93-b3bb-4c0e635568c2.pdf) |
| 28 Apr - Torrent Pharma shareholders approved amalgamation scheme with JB Chemicals on April 28, 2026. | [Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting 28 Apr - Torrent Pharma shareholders approved amalgamation scheme with JB Chemicals on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b863deb-1691-49d4-bc27-4a909c7ac8bf.pdf) |
| 28 Apr - Torrent Pharma shareholders approved amalgamation scheme with JB Chemicals on April 28, 2026. | [Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting 28 Apr - Torrent Pharma shareholders approved amalgamation scheme with JB Chemicals on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1b863deb-1691-49d4-bc27-4a909c7ac8bf.pdf) |
| 28 Apr - Torrent Pharma shareholders approved amalgamation of J.B. Chemicals & Pharmaceuticals on April 28, 2026. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 28 Apr - Torrent Pharma shareholders approved amalgamation of J.B. Chemicals & Pharmaceuticals on April 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2d475de9-1bba-43a6-8263-02379619e559.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff8314b3-63f3-4741-871f-83b50a44e1d9.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72f4c6a4-acaf-4542-9ee0-563a58f66ed3.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bf33b4fb-38ba-401a-85c7-58c0a36fed92.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6fe845d6-918b-4ab8-9efd-36588666eeed.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:26:07.577Z.